The problem of pertussis at the child age;Problematika pertuse v dětském věku

Cesko-Slovenska Pediatrie

Volumn 61, Issue 1, 2006, Pages 6-11

  Duřpektová, Marie ^a,d   Hrstkova H ^b   Durpektova M ^c   Valnickova Z ^c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c Ambulance Alergologie a Klinické Imunologie   (Czech Republic)

^d NONE   (Czech Republic)

Author keywords

Cough; Pertussis; Pertussis toxin; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHILD; COUGHING; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; VACCINATION;

EID: 31144456481     PISSN: 00692328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Elliott E, McIntyre P, Ridley G, Morris A, Massie J, McEniery J, Knight G. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr. Infect. Dis. J. 2004;23(3):246-252.
2. Fuchsbichler S. Pertussis Toxin ELISA. Product Information Booklet 2003.
3. Gilberg S, Njamkepo E, Du Chatelet IP, Partouche H, Gueirard P, Ghasarossian C, Schlumberger M, Guiso N. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J. Infect. Dis. 2002;186(3):415-418.
4. Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SG. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J. Pediat. 1998;132(6):983-988.
5. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. New Engl. J. Med. 1996;334(8):341-349.
6. Heininger U, Kleemann WJ, Cherry DJ. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics. 2004;114:e9-e15.
7. Heiniger U. Recent progress in clinical and basic pertussis research. Europ. J. Pediatr. 2001;160:203-213.
8. Konda T, Kamachi K, Iwaki M, Matsunaga Y. Distribution of pertussis antibodies among different age groups in Japan. Vaccine. 2002;20(13-14):1711- 1717.
9. von König CH, Halperin S, Riffelmann M, et al. Pertussis of adults and infants. Lancet Infect. Dis. 2002;2:744-750.
10. Kříž B, Částková J, Šrámová H, Švandová E. Více- účelový sérologický přehled protilátek proti vybraným infekcím, u nichž se provádí očkování. Zprávy centra epidemiologie a mikrobiologie 2003. ISSN 1211-7358.
11. de Melker HE, et al. Specifity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Mikrobiol. 2000;38(2):800-806.
12. Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 2001;7(Suppl 3):526-528.
13. Müller FM, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: State of the Art in 1997. J. Clin. Microbiol. 1997;35:2435-2443.
14. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet. 1997;350(9091)29:1569-1577.
15. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 2005;133(1):159-171.
16. Ranganathan S, Tasker R, Booy R, Habibi P, Nadel S, Britto J. Pertussis is increasing in unimmunized infants: is a change in policy needed? Arch. Dis. Child. 1999;80(3):297-299.
17. Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Europ. J. Pediatr. 2000;59(12):898-900.
18. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16(20):1907-1916.
19. Vospělová J, Zapletalová J. Stále aktuální pertuse. Pediatrie pro praxi. 2004;4:204-206.